Clinical Trial Update: The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the effect of bevacizumab and ziv-aflibercept in diabetic macular edema. The study covers Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN